The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment-Reference-Cited by-同舟云学术

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

Published:2011-08 Issue:8 Volume:17 Page:1651-1664
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Schicho Rudolf,Bashashati Mohammad,Bawa Misha,McHugh Douglas,Saur Dieter,Hu Huang-Ming,Zimmer Andreas,Lutz Beat,Mackie Ken,Bradshaw Heather B.,McCafferty Donna-Marie,Sharkey Keith A.,Storr Martin

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference54 articles.

1. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

2. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

3. The orphan receptor GPR55 is a novel cannabinoid receptor

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of GPR55 alleviates neuropathic pain and chronic inflammation;Biotechnology and Applied Biochemistry;2024-09

2. GPR55 Antagonist CID16020046 Attenuates Obesity-Induced Airway Inflammation by Suppressing Chronic Low-Grade Inflammation in the Lungs;International Journal of Molecular Sciences;2024-07-04

3. Modulation of neuroinflammation and oxidative stress by targeting GPR55 – new approaches in the treatment of psychiatric disorders;Molecular Psychiatry;2024-05-25

4. Anti-Inflammatory Effects of GPR55 Agonists and Antagonists in LPS-Treated BV2 Microglial Cells;Pharmaceuticals;2024-05-24

5. An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives;Bioorganic Chemistry;2023-11